[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Bio Stocks™ @BioStocks on x 68.6K followers
Created: 2025-07-23 12:11:04 UTC
$ARWR should Sarepta fail to make either the $100M or $200M near-term payment associated with enrollment of ARO-DM1 cohorts, or fail to make any development or commercial milestone payment, Arrowhead would have the right to terminate the agreement. $SRPT
XXXXX engagements
Related Topics 100m $srpt $200m $100m stocks $arwr sarepta therapeutics inc stocks healthcare